Signal active
Organization
Contact Information
Overview
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.
About
Software, Electronics, Manufacturing, Nanotechnology
2002
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cambrios Technologies headquartered in United States, North America, operates in the Software, Electronics, Manufacturing, Nanotechnology sector. The company focuses on Software and has secured $11.7B in funding across 144 round(s). With a team of 11-50 employees, Cambrios Technologies is actively contributing to advancements in Software. Their latest funding round, Series D - Cambrios Technologies, raised $14.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
9
13
0
$81.1M
Details
7
Cambrios Technologies has raised a total of $81.1M in funding over 7 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2011 | Late Stage Venture | 9.4M | ||
2012 | Late Stage Venture | 5.0M | ||
2005 | Early Stage Venture | 12.0M | ||
2009 | Late Stage Venture | 14.5M |
Investors
Cambrios Technologies is funded by 16 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Alloy Ventures | - | FUNDING ROUND - Alloy Ventures | 1.8M |
Matthew Gibbs | - | FUNDING ROUND - Matthew Gibbs | 1.8M |
Cambrios Technologies | - | FUNDING ROUND - Cambrios Technologies | 1.8M |
Oxford Bioscience Partners | - | FUNDING ROUND - Oxford Bioscience Partners | 1.8M |
Recent Activity
There is no recent news or activity for this profile.